Dynamic Cardiovascular Responses to Infusions of Atrial Natriuretic Factor in Humans

• Published in: Hypertension (Dallas, Tex. 1979) Tex. 1979), 1988-06, Vol.11 (6, Part 1), p.537-544
• Main Authors: EBERT, THOMAS J, SKELTON, MEREDITH M, COWLEY, ALLEN W
• Format: Article
• Language: English
• Subjects: Adult; Arterial hypertension. Arterial hypotension; Atrial Natriuretic Factor - administration & dosage; Atrial Natriuretic Factor - adverse effects; Atrial Natriuretic Factor - blood; Atrial Natriuretic Factor - pharmacokinetics; Biological and medical sciences; Blood and lymphatic vessels; Blood Pressure - drug effects; Cardiac Output - drug effects; Cardiology. Vascular system; Central Venous Pressure - drug effects; Clinical manifestations. Epidemiology. Investigative techniques. Etiology; Forearm - blood supply; Hemodynamics - drug effects; Homeostasis - drug effects; Hormones - blood; Humans; Hypotension - chemically induced; Infusions, Intravenous; Injections, Intravenous; Medical sciences; Norepinephrine - blood; Sympathetic Nervous System - drug effects; Time Factors; Vascular Resistance - drug effects
• ISSN: 0194-911X; 1524-4563
• DOI: 10.1161/01.hyp.11.6.537

We sought to demonstrate a hypotensive effect from infusions of atrial natriuretic factor (ANF) into humans and to describe the mechanism(s) of this effect. Cardiovascular and hormonal responses to human ANF-(99–126) (125 ng/kg bolus followed by a 30-minute infusion at 25 ng/kg/min) were determined in eight conscious volunteers and compared with responses of eight timecontrol subjects who received isotonic saline. Baseline levels of ANF (52.8 ± 5.5 pg/ml) increased 8.8-fold after 30 minutes of ANF infusion but were unchanged in the time controls. Plasma levels of renin, aldosterone, vasopressin, sodium, potassium, and osmolality did not change during infusions. A transient 5% reduction in mean arterial pressure related to a 12% reduction in peripheral resistance was observed 10 minutes after the priming bolus of ANF. This response was not sustained during the remainder of the ANF infusion period, nor did it occur in two additional subjects who received ANF infusions without the priming bolus. Steady state responses consisted of significant reductions in central venous pressure (15%), stroke volume (13%), and cardiac output (10%), but no reduction in blood pressure. Plasma norepinephrine levels and peripheral resistance increased (34% and 9%, respectively) during ANF administration. These data indicate that steady state responses to ANF in humans consist of decreases in cardiac filling pressures, which reduce cardiac output, unload cardiopulmonary baroreceptors, and activate the sympathetic nervous system. Blood pressure is well maintained despite striking increases in plasma ANF.